Premature infants whose mothers received a prenatal infusion of magnesium sulfate -- also known as Epsom salts -- were 50% less likely to develop cerebral palsy, U.S. researchers found. About 4% of babies whose mothers took a placebo solution developed moderate or severe cerebral palsy, compared to 2% of infants whose mothers received the mineral compound, according to the government-funded study.

Related Summaries